Is Wegovy Covered by Medicare Part D
Most people with Medicare Part D cannot get Wegovy covered through their standalone prescription drug plan, because Medicare Part D does not pay for antiobesity medications in people without diabetes. Some Medicare Advantage plans may include coverage for weight-loss medications in certain medical policies or bundled care programs, and people on Medicare who also have a qualifying condition such as obesity-related type 2 diabetes may find coverage options via the plan’s formulary or through compassionate use. Below you will find a verified status overview, how Medicare defines medically necessary weight loss, and practical steps to discuss coverage with your plan and clinician.
Key Coverage Facts at a Glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Standard Medicare Part D coverage for Wegovy | Generally not covered for weight loss alone; limited to people with diabetes in some plans | Policy summary / Plan documents |
| Medicare Advantage coverage for weight-loss medications | Varies by plan and may be available under specific medical policies or disease management programs | Plan Evidence of Coverage |
| BMI threshold often used by plans | 30 or higher, or 27+ with weight-related condition, if covered at all | Formulary criteria |
| Typical cost-sharing when covered | Coinsurance or copay applies; prior authorization and quantity limits are common | Formulary and policy documents |
| Alternative Medicare-covered options | Orlistat (Xenical or generics) may be covered for BMI 30+ or BMI 27+ with comorbidities; lifestyle programs may be covered via Medicare Part B | Medicare policy guidance |
How Medicare Part D Defines Coverage
Medicare Part D plans cover medications that are FDA-approved and deemed medically necessary under the member’s plan benefits. Antiobesity medications such as semaglutide (Wegovy) are not routinely covered for weight loss alone because Medicare Part D guidance generally excludes these drugs when used for obesity without an approved indication such as diabetes. If a plan chooses to cover Wegovy, it will do so only after meeting strict prior authorization requirements, typically including documented diabetes or other specified metabolic conditions and a documented medical necessity determination.
What Medicare Considers Medically Necessary Weight Loss
For Medicare, medically necessary weight-loss pharmacotherapy is generally limited to individuals who meet clinical criteria, such as having a BMI of 30 or higher with documented weight-related complications, or a BMI of 27 or higher with conditions like type 2 diabetes, hypertension, or dyslipidemia. Plans may reference these clinical criteria in their evidence of coverage or medical policy, and coverage is usually contingent on enrollment in a structured diet, exercise, and behavioral program. Semaglutide for chronic weight management may be covered only when these criteria are met and when the medication is listed on the plan’s formulary with appropriate prior authorization.
Wegovy and Medicare Part D: Verified Status
Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related comorbidity. However, Medicare Part D coverage is not guaranteed and varies significantly by plan. Most standalone Part D plans adhere to coverage rules that limit antiobesity drug coverage to people with diabetes, and they may place Wegovy on a higher tier or require step therapy. In contrast, some Medicare Advantage plans with prescription drug coverage may include broader weight-loss medication benefits under specific care models or disease management programs. If you are wondering, “Is Wegovy covered by Medicare Part D?” the short answer is: not as a standard benefit; coverage is only possible through specific plan formularies and after meeting stringent medical and prior authorization criteria.
How to Check Your Plan’s Coverage
Review the Evidence of Coverage and Formulary
Every Medicare Part D and Medicare Advantage plan provides an Evidence of Coverage document and a formulary that list covered drugs, tiers, and requirements such as prior authorization or quantity limits. To check whether Wegovy is covered, locate your plan’s formulary on the plan sponsor’s website or by calling the member services number on your ID card. Search for semaglutide or Wegovy and review any restrictions, such as whether you must have diabetes, a specific BMI threshold, or whether the plan requires a comprehensive weight-management program alongside the medication.
Steps to Request Coverage or an Exception
- Talk with your clinician about whether semaglutide is appropriate for your health goals and medical conditions.
- Ask your clinician to submit a prior authorization request that includes documentation of your diagnosis, BMI, comorbidities, and previous weight-loss efforts.
- If your plan denies coverage, you or your clinician can appeal the decision with additional medical documentation or request an exception based on medical necessity.
- Contact your Medicare plan’s member services to confirm your specific benefits, tier placement, and cost-sharing for Wegovy or alternative covered medications.
Alternative Options When Wegovy Isn’t Covered
Other Pharmacotherapy Options Under Medicare
If Wegovy is not covered, other weight-loss medications may be covered depending on the plan. Orlistat, which is available over the counter at lower doses (alli) and by prescription at higher doses (Xenical), is a Medicare-covered option for people with a BMI of 30 or higher, or BMI 27 or higher with comorbidities, when prescribed as part of a comprehensive weight-management program. Because formularies and policies vary, it’s important to confirm tier, cost-sharing, and any quantity limits with your plan. Your clinician may also discuss off-label options and whether they can be billed in a way that aligns with Medicare coverage rules.
Non-Pharmacotherapy Benefits That May Help
- Medicare Part B may cover behavioral counseling for weight loss in certain primary care or intensive behavioral therapy settings if you meet criteria.
- Some Medicare Advantage plans include coverage for structured weight-management programs, nutrition counseling, or digital health tools as part of chronic disease or wellness benefits.
- Community-based programs such as Diabetes Self-Management Education and Support (DSMES) or other recognized lifestyle programs may be covered and can support sustainable weight loss alongside or instead of pharmacotherapy.
When Coverage May Change
Medicare policies and formularies can evolve, and a medication that is not covered today could become covered under new plan designs or regulatory changes. If you are advocating for coverage, staying engaged with your clinician and plan is important. Updates to evidence, new outcomes data, or changes in Medicare Advantage plan contracts can affect access to weight-loss medications over time. If you have diabetes or another qualifying condition, periodic reevaluation of your plan’s formulary may create new opportunities for coverage, so it’s worth checking annually or when your treatment goals change.
Next Steps and Talking Points with Your Clinician and Plan
To navigate coverage for Wegovy or other weight-loss medications under Medicare, start by clarifying your diagnosis, BMI, and comorbidities. Bring this information to your clinician to discuss whether pharmacotherapy aligns with your goals and to initiate a prior authorization if appropriate. Ask your Medicare plan directly about whether Wegovy is listed on the formulary, what tier it is on, and what medical criteria or appeals process apply if it is not covered. Comparing plans during open enrollment or when you have a qualifying life event may also help you find a Medicare Advantage option that includes broader coverage for weight-loss medications.